Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment

Aging and Cognitive FunctionsMultiple Sclerosis

Cognition in multiple sclerosis: Between cognitive reserve and brain volume

J Neurol Sci.

Fenu G, Lorefice L, Arru M, Sechi V, Loi L, Contu F, Cabras F, Coghe , Frau J, Fronza M, Sbrescia G, Lai V, Boi M, Mallus S, Murru S, Porcu A, Barracciu MA, Marrosu MG, Cocco E

doi: 10.1016/j.jns.2018.01.011.

Aging and Cognitive FunctionsMultiple Sclerosis

Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures

J Neurol.

Santangelo G, Bisecco A, Trojano L, Sacco R, Siciliano M, d'Ambrosio A, Della Corte M, Lavorgna L, Bonavita S, Tedeschi G, Gallo A

doi: 10.1007/s00415-018-8905-9.

Multiple Sclerosis

Detection of Leukocortical Lesions in Multiple Sclerosis and Their Association with Physical and Cognitive Impairment: A Comparison of Conventional and Synthetic Phase-Sensitive Inversion Recovery MRI

AJNR Am J Neuroradiol.

Forslin Y, Bergendal Å, Hashim F, Martola J, Shams S, Wiberg MK, Fredrikson S, Granberg T

doi: 10.3174/ajnr.A5815.

Aging and Cognitive FunctionsMultiple Sclerosis

Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach

Eur J Neurol.

Uher T, Vaneckova M, Sormani MP, Krasensky J, Sobisek L, Dusankova JB, Seidl Z, Havrdova E, Kalincik T, Benedict RH, Horakova D

doi: 10.1111/ene.13200.

Aging and Cognitive FunctionsMultiple Sclerosis

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

J Neurol.

Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M; Golden Study Group

doi: 10.1007/s00415-017-8642-5.

RECOMMENDED

Multiple Sclerosis

Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis

Eur Neurol.

Ruberte E, Sinnecker T, Amann M, Gaetano L, Naegelin Y, Penner IK, Kuhle J, Derfuss T, Kappos L, Granziera C, Wuerfel J, Yaldizli Ö

doi: 10.1159/000495798.

Multiple Sclerosis

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Brain

Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J

doi: 10.1093/brain/awy154.

Multiple Sclerosis

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

J Neuroinflammation.

Nakamura Y, Gaetano L, Matsushita T, Anna A, Sprenger T, Radue EW, Wuerfel J, Bauer L, Amann M, Shinoda K, Isobe N, Yamasaki R, Saida T, Kappos L, Kira JI

doi: 10.1186/s12974-018-1295-1.

Multiple Sclerosis

Progressive multiple sclerosis: from pathogenic mechanisms to treatment

Brain.

Correale J, Gaitán MI, Ysrraelit MC, Fiol MP

doi: 10.1093/brain/aww258.

Related content

Cognition in multiple sclerosis: Between cognitive reserve and brain volume

Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures

Detection of Leukocortical Lesions in Multiple Sclerosis and Their Association with Physical and Cognitive Impairment: A Comparison of Conventional and Synthetic Phase-Sensitive Inversion Recovery MRI

Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

Progressive multiple sclerosis: from pathogenic mechanisms to treatment